Entero Therapeutics Inc Com Par $0.0001 (New) Soared
Fri, Oct 04, 2024 at 07:31 PM
Entero Therapeutics Inc Com Par $0.0001 (New) (ENTO:NASDAQ) shot up at $0.6, a gain of 73.3%. On Fri, Oct 04, 2024, ENTO:NASDAQ touched a New 2-Week High of $0.6. The stock got featured on our News Catalysts scanner on Tue, Sep 10, 2024 at 10:32 AM in the 'AGREEMENT' category. From Fri, Sep 20, 2024, the stock recorded 40.00% Up Days and 36.36% Green Days
The stock spiked on Fri, Oct 04, 2024 at $0.75 with a volume of 9M+.
About Entero Therapeutics Inc Com Par $0.0001 (New) (ENTO:NASDAQ)
First Wave BioPharma Inc is a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal diseases.
Top 10 Gainers:
- Chanson International Holding (CHSN:NASDAQ), 387.17%
- Phoenix Motor Inc. (PEV:NASDAQ), 207.91%
- Entero Therapeutics Inc Com Par $0.0001 (New) (ENTO:NASDAQ), 73.32%
- Beneficient (BENF:NASDAQ), 58.82%
- Forward Industries, Inc. (FORD:NASDAQ), 52.41%
- Cue Biopharma, Inc. (CUE:NASDAQ), 41.6%
- Snail, Inc. (SNAL:NASDAQ), 36.42%
- Alpha Technology Group Limited (ATGL:NASDAQ), 36.11%
- UP Fintech Holding Limited (TIGR:NASDAQ), 34.82%
- Boqii Holding Limited American Depositary Shares representing Class A (BQ:NYSEMKT), 34.54%